Quaker Wealth Management’s Novo Nordisk NVO Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q3
$8.15K Sell
215
-200
-48% -$9.22K ﹤0.01% 305
2026
Q2
$19.9K Buy
415
+200
+93% +$8.59K 0.01% 237
2026
Q1
$7.9K Sell
215
-400
-65% -$19K ﹤0.01% 310
2025
Q4
$31.3K Buy
615
+400
+186% +$20.5K 0.01% 213
2025
Q3
$11.9K Hold
215
– – ﹤0.01% 268
2025
Q2
$14.8K Buy
+215
New +$14.6K 0.01% 265

Other funds holding NVO

Quaker Wealth Management's NVO Position: Q3 2026 in Review

Quaker Wealth Management reduced its Novo Nordisk (NVO) stake by 48% in Q3 2026, selling an estimated $9.22K and leaving 215 shares worth $8.15K. The position accounts for ﹤0.01% of the portfolio, ranked #305.

Quaker Wealth Management first reported a position in NVO in Q2 2025 and has held it in 6 quarters since. The position peaked at $31.3K in Q4 2025. 1,237 funds tracked by Wall St. Rank hold NVO as of Q3 2026.

  • Quaker Wealth Management held 215 shares of Novo Nordisk worth $8.15K as of Q3 2026.
  • Quaker Wealth Management sold 200 Novo Nordisk shares in Q3 2026, an estimated $9.22K.
  • Novo Nordisk made up ﹤0.01% of Quaker Wealth Management's portfolio in Q3 2026, its #305 holding.
  • Quaker Wealth Management first reported a position in Novo Nordisk in Q2 2025 and has held it in 6 quarters since.
  • Quaker Wealth Management's Novo Nordisk position peaked at $31.3K in Q4 2025.
  • 1,237 funds tracked by Wall St. Rank held Novo Nordisk as of Q3 2026.

Based on Quaker Wealth Management's 13F filing for Q3 2026, filed 22 Oct 2026.